Research Article
The Derivative of Tripterygium wilfordii Hook F—Kunxian Capsule, Attenuated Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Table 1
Clinical and demographic characteristics of patients with rheumatoid arthritis.
| Study | Number of participants (male/female) | Age (years) | Intervention | Duration | Outcomes | Experimental | Control | Experimental | Control | Experimental | Control |
| Ji [20] | 30 (3/27) | 30 (5/25) | 47.93 ± 11.57 | 52.30 ± 15.84 | KXC 0.6 g bid + control | MTX 10 mg qw, NSAIDs | 12 w | ①②③④⑤⑥ | Jia [22] | 30 (9/21) | 30 (8/22) | 22–70 | 20–70 | KXC 0.6 g tid + control | MTX 10–15 mg qw, folic acid 10 mg qw | 12 w | ①②③④⑤⑥⑦ | Lu et al. [23] | 20 (7/13) | 20 (8/12) | 60–73 (67) | 61–72 (66) | KXC 0.3–0.6 g tid + MTX 7.5 mg | MTX 7.5–15 mg qw | 24 w | ①②③④⑤ | Quan and Wang [24] | 78 | 78 | 54.29 ± 11.08 | 56.04 ± 11.42 | KXC 0.3–0.6 g tid + control | HCQ 0.2 g bid | 24 w | ④⑤⑥⑦ | Zhang and Zhang [21] | 36 (13/23) | 36 (15/21) | 45.6 ± 10.2 | 46.2 ± 9.8 | KXC 0.3 tid + control | MTX 10 mg qw + NSAIDs | 12 w | ③④⑤⑥ | Tian [16] | 30 (7/23) | 30 (6/24) | 61.37 ± 10.43 | 59.47 ± 11.77 | KXC 0.3 g tid + control | LEF 20 mg qd | 24 w | ④⑤⑥ | Liu et al. [18] | 50 (4/46) | 30 (2/28) | 36–62 | 35–59 | KXC 0.6 g tid | LEF 20 mg qn | 12 w | ④⑤⑥⑦ | Lu [19] | 30 (11/19) | 30 (10/20) | 46.31 ± 5.62 | 47.50 ± 5.71 | KXC 0.6 g tid | MTX 10–15 mg qw | 6 m | ③④⑤ | Lin et al. [17] | 80 (24/56) | 79 (13/66) | 52.14 ± 9.70 | 48.62 ± 13.01 | KXC 0.3–0.6 g tid | MTX 10–15 mg qw | 12 w | ①②③④⑤⑥⑦ |
|
|
Note. KXC: Kunxian Capsule; MTX: methotrexate; LEF: leflunomide; HCQ: hydroxychloroquine; ① TJC: tender joint counts; ② SJC: swollen joint counts; ③ DMS: duration of morning stiffness; ④ ESR: erythrocyte sedimentation rate; ⑤ CRP: C-reactive protein; ⑥ RF: rheumatoid factor; ⑦ CCP: anticyclic citrullinated peptide antibody. Values are mean ± standard deviation (SD).
|